Oxytocin-EA

SECTION 2: Hazards identification

_______________________________________________________________________________________

Hazard statements

This product is classified as: This product is classified as: Xn, Harmful. Hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to Dangerous Goods (DG) Code, IATA and IMDG/IMSBC criteria. R61 – May cause harm to the unborn child.

Precautionary statements

S45 – In case of accident or if you feel unwell, contact a doctor or Poisons Information Centre immediately (show the label where possible). SUSMP: S4

ADG classification

None allocated. Not a Dangerous Good under the DG Code.

UN Number

None allocated.

Signal word

WARNING

Prevention

P102: Keep out of reach of children. P201: Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required.

Response

P337: If eye irritation persists: seek medical attention P352: Wash with plenty of soap and water P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting P308+P313: If exposed or concerned: Get medical advice. P370+P378: Not combustible. Use extinguishing media suited to burning materials

Storage

P405: Store locked up. P402+P404: Store in a dry place. Store in a closed container. P403+P435: Sore in a well-ventilated place. Keep cool

Disposal

P501: Dispose of contents and containers as specified on the registered label EMERGENCY OVERVIEW _______________________________________________________________________________________ Physical Description & Colour: Clear, colourless liquid. Odour: Mild odour.

Health hazards

May cause harm to unborn children. If injected into pregnant women, premature labour may be induced. IN ALL SUCH CASES, SEEK IMMEDIATE MEDICAL ADVICE.

Potential health effects

_______________________________________________________________________________________ This product has no pharmacological effect on the human male. However, if injected into pregnant women, premature labour may be induced. IN ALL SUCH CASES, SEEK IMMEDIATE MEDICAL ADVICE. Inhalation: Short Term Exposure: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. How-ever product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. How-ever product may be irritating but is unlikely to cause anything more than mild transient discomfort which should disappear once contact ceases. Long Term Exposure: No data for health effects associated with long term eye exposure. Eye Contact: Short Term Exposure: Exposure via eyes is considered to be unlikely. This product may be mildly irritating to eyes, but is unlikely to cause anything more than mild discomfort which should disappear once product is removed. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product maybe mildly irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SW: No significant ingredient is classified as carcinogenic by SW. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.